Mithun Vinod Shah
Overview
Explore the profile of Mithun Vinod Shah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
676
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Gurney M, Baranwal A, Rosenthal A, Kharfan-Dabaja M, Kenderian S, Lin Y, et al.
JAMA Oncol
. 2024 Feb;
10(4):532-535.
PMID: 38386311
No abstract available.
12.
Baranwal A, Basmaci R, He R, Viswanatha D, Greipp P, Murthy H, et al.
Blood Adv
. 2023 Nov;
8(3):562-570.
PMID: 38011614
No abstract available.
13.
Murthy H, Zhang M, Chen K, Ahmed S, Deotare U, Ganguly S, et al.
Blood Adv
. 2023 Oct;
7(22):7007-7016.
PMID: 37792849
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy with a poor prognosis and considered incurable with conventional chemotherapy. Small observational studies reported allogeneic hematopoietic cell transplantation (allo-HCT)...
14.
Zanwar S, Jacob E, Greiner C, Pavelko K, Strausbauch M, Anderson E, et al.
Blood Cancer J
. 2023 Sep;
13(1):151.
PMID: 37752130
Upfront autologous stem cell transplant (ASCT) is the standard of care for newly diagnosed multiple myeloma (MM) patients. However, relapse is ubiquitous and therapy-related myeloid neoplasms (t-MN) post-ASCT are commonly...
15.
Xie Z, Lasho T, Khurana A, Ferrer A, Finke C, Mangaonkar A, et al.
Haematologica
. 2023 Aug;
109(2):509-520.
PMID: 37646653
While novel radioisotope therapies continue to advance cancer care, reports of therapy-related myeloid neoplasms (t-MN) have generated concern. The prevalence and role of clonal hematopoiesis (CH) in this process remain...
16.
Shah M, Tran E, Shah S, Chhetri R, Baranwal A, Ladon D, et al.
Blood Cancer J
. 2023 Apr;
13(1):51.
PMID: 37041128
Revised diagnostic criteria for myeloid neoplasms (MN) issued by the International Consensus Classification (ICC) and the World Health Organization (WHO) recommended major change pertaining to TP53-mutated (TP53) MN. However, these...
17.
Al-Kali A, Nanaa A, Viswanatha D, He R, Nguyen P, Jevremovic D, et al.
Blood Cancer J
. 2023 Apr;
13(1):49.
PMID: 37032414
No abstract available.
18.
Baranwal A, Chhetri R, Yeung D, Clark M, Shah S, Litzow M, et al.
Bone Marrow Transplant
. 2023 Apr;
58(7):769-776.
PMID: 37012415
Therapy-related myeloid neoplasms (t-MN) are aggressive myeloid neoplasms. Factors predicting post-allogeneic stem cell transplant (alloSCT) survival are not well-known. We studied the prognostic utility of factors at: t-MN diagnosis, pre-alloSCT,...
19.
Ragon B, Shah M, DSouza A, Estrada-Merly N, Gowda L, George G, et al.
Blood Adv
. 2023 Feb;
7(12):2746-2757.
PMID: 36827681
The overall survival (OS) has improved significantly in multiple myeloma (MM) over the last decade with the use of proteasome inhibitor and immunomodulatory drug-based combinations, followed by high-dose melphalan and...
20.
Hiwase D, Hahn C, Tran E, Chhetri R, Baranwal A, Al-Kali A, et al.
Blood
. 2022 Dec;
141(9):1087-1091.
PMID: 36574363
No abstract available.